Innovate in India for Inclusiveness

Abstract*

The development objective of Innovate in India for Inclusiveness is to facilitate innovation in biopharmaceutical products and medical devices that address public health priorities in India. This project has three components. 1) The first component, Strengthening the pilot-to-market innovation ecosystem, aims to provide grant funding to support the creation of centers of excellence for validation, early stage bio-manufacturing, clinical development... Show More

Development Objective

The proposed project development objective (PDO) is to facilitate innovation in biopharmaceutical products and medical devices that address public health priorities in India

Key Details

Project Details

Project ID
P156241
Status
Active
Team Leader
Amadou Dem , Dinesh Nair
Borrower 2
India

Country
India
Disclosure Date
August 9, 2016
Approval Date
(as of board presentation)
May 31, 2017
Effective Date
May 23, 2018

Total Project Cost 1
US$ 250.00 million
Implementing Agency
Biotechnology Industry Research Assistance Council
Region
South Asia
Fiscal Year 3
2017

Commitment Amount
US$ 125.00 million
Environmental Category
B
Last Update Date
May 2, 2024
Closing Date
June 23, 2025

Consultant Services required
Yes
Last Stage Reached
BANK APPROVED

Notes
1. Total project cost includes funding from World Bank and non-bank sources in US$ millions. Active and Closed projects show current commitments. Proposed (pipeline) and dropped projects show the forecast amount. The commitment amount for projects in the pipeline is indicative and may be modified during the project preparation.
2. Borrower refers to the Borrower of a Loan or Recipient of a Grant.
3. ”Fiscal Year” is the fiscal year in which the project was approved (or dropped if the status is dropped). The World Bank's fiscal year is from July 1 - June 30. For example, a fiscal year of 1996 corresponds to July 1, 1995 - June 30, 1996.

Sectors

Themes

FY17 - Human Development and Gender

FY17 - Disease Control6%
- FY17 - Non-communicable diseases6%
FY17 - Gender6%
FY17 - Health Systems and Policies72%
- FY17 - Health System Strengthening72%

FY17 - Private Sector Development

FY17 - Business Enabling Environment52%
- FY17 - Innovation and Technology Policy52%
FY17 - Enterprise Development6%
- FY17 - MSME Development6%

Project Map

Interactive Map

Finances

Financing Plan (US$ Millions)

Financier	Commitments
International Bank for Reconstruction and Development	125.00
Borrower/Recipient	125.00

Total Project Financing (US$ Millions)

Product Line	IBRD/IDA
IBRD Commitment	125.00
IDA Commitment	N/A
IBRD + IDA Commitment	125.00

Lending Instrument
Grant Amount	N/A
Total Project Cost**	250.00

Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025

No data available.

Detailed Financial Activity as of March 31, 2025

Download:

Period	Financier	Transaction Type	Amount (US$)
May 15, 2021	IBRD-87510	Int Charges	115,900.68
May 15, 2021	IBRD-87510	Int Charges	6,773.21
Nov 15, 2020	IBRD-87510	Int Charges	1,171.31
Nov 15, 2020	IBRD-87510	Int Charges	11,261.04
Nov 15, 2020	IBRD-87510	Int Charges	129,861.05
Nov 15, 2020	IBRD-87510	Int Charges	143,523.81
Jan 21, 2021	IBRD-87510	Loan Disb	5,449,033.00
Nov 15, 2021	IBRD-87510	Int Charges	107,992.86
Nov 15, 2021	IBRD-87510	Int Charges	184,844.52
Jun 1, 2021	IBRD-87510	Loan Disb	6,446,323.00
Dec 13, 2021	IBRD-87510	Loan Disb	1,600,417.50
May 15, 2022	IBRD-87510	Int Charges	103,816.56
May 15, 2022	IBRD-87510	Int Charges	199,140.81
Jul 12, 2022	IBRD-87510	Loan Disb	6,416,915.50
Nov 15, 2022	IBRD-87510	Int Charges	738,856.40
Nov 15, 2022	IBRD-87510	Int Charges	99,687.39
Dec 27, 2022	IBRD-87510	Loan Disb	3,304,913.20
May 15, 2023	IBRD-87510	Int Charges	67,153.78
May 15, 2023	IBRD-87510	Int Charges	92,407.97
May 15, 2023	IBRD-87510	Int Charges	1,306,043.00
Apr 21, 2023	IBRD-87510	Loan Cancel	20,400,000.00
Aug 1, 2023	IBRD-87510	Loan Disb	5,115,379.00
Nov 15, 2023	IBRD-87510	Int Charges	30,563.74
Nov 15, 2023	IBRD-87510	Int Charges	60,196.19
Nov 15, 2023	IBRD-87510	Int Charges	1,684,293.10
Nov 15, 2023	IBRD-87510	Loan Repay	2,450,931.00
Apr 22, 2024	IBRD-87510	Loan Cancel	14,200,000.00
Mar 28, 2024	IBRD-87510	Loan Disb	2,363,207.80
May 15, 2024	IBRD-87510	Int Charges	1,789,882.50
May 15, 2024	IBRD-87510	Loan Repay	2,514,536.50
May 15, 2024	IBRD-87510	Int Charges	10,595.34
May 15, 2024	IBRD-87510	Int Charges	58,447.32
Feb 20, 2024	IBRD-87510	Loan Disb	1,397,922.00
May 31, 2017	IBRD-87510	Loan Commitment	125,000,000.00
May 23, 2018	IBRD-87510	Loan Disb	312,500.00
May 23, 2018	IBRD-87510	Fee Charges	312,500.00
Jun 20, 2019	IBRD-87510	Loan Disb	1,502,326.80
May 15, 2019	IBRD-87510	Int Charges	6.02
Nov 6, 2018	IBRD-87510	Loan Disb	97,660.10
Feb 14, 2019	IBRD-87510	Loan Disb	2,583,396.20
Nov 21, 2018	IBRD-87510	Loan Disb	86,585.96
Nov 15, 2018	IBRD-87510	Int Charges	123,827.45
Nov 15, 2018	IBRD-87510	Int Charges	4,873.61
Mar 30, 2020	IBRD-87510	Loan Disb	3,727,839.00
Sep 16, 2019	IBRD-87510	Loan Disb	744,276.10
Nov 15, 2019	IBRD-87510	Int Charges	384.43
Nov 15, 2019	IBRD-87510	Int Charges	104,155.89
Sep 27, 2019	IBRD-87510	Loan Disb	1,276,516.20
Nov 15, 2019	IBRD-87510	Int Charges	5,150.11
Nov 15, 2019	IBRD-87510	Int Charges	148,993.80
Apr 1, 2019	IBRD-87510	Loan Disb	1,275,568.40
Jun 26, 2019	IBRD-87510	Loan Disb	816,229.50
May 15, 2019	IBRD-87510	Int Charges	71.86
May 15, 2019	IBRD-87510	Int Charges	152,376.56
May 15, 2019	IBRD-87510	Int Charges	31,742.66
Oct 14, 2020	IBRD-87510	Loan Disb	6,778,637.00
Jun 26, 2020	IBRD-87510	Loan Disb	3,218,816.80
May 15, 2020	IBRD-87510	Int Charges	734.28
May 15, 2020	IBRD-87510	Int Charges	9,063.16
May 15, 2020	IBRD-87510	Int Charges	137,903.66
May 15, 2020	IBRD-87510	Int Charges	174,305.73
Dec 20, 2019	IBRD-87510	Loan Disb	5,589,907.50
May 15, 2021	IBRD-87510	Int Charges	1,481.66
May 15, 2021	IBRD-87510	Int Charges	150,180.40

Footnotes

Ratings

IMPLEMENTATION RATINGS

No data available.

COMPLETION RATINGS

INDICATOR	IMPLEMENTATION COMPLETION & RESULTS REPORT:
Outcomes
Risk to Development Outcome
Bank Performance
Borrower Performance
Government Performance
Implementing Agency

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATOR		BASELINE	CURRENT	TARGET

Number of products addressing public health priorities advanced at least one step on the product development pathway Value 0.00 7.00 0.00
Date November 14, 2016 April 16, 2020
Comment
Number of new IP registrations or product prototypes Value 0.00 13.00 5.00
Date November 14, 2016 April 16, 2020
Comment
Number of technologies licensed for manufacturing or commercialization Value 0.00 0.00 0.00
Date November 14, 2016 April 16, 2020
Comment
Number of TTOs established Value 0.00 5.00 0.00
Date November 14, 2017 April 16, 2020
Comment
Number of companies using shared facilities supported by the project Value 0.00 14.00 20.00
Date November 14, 2017 April 16, 2020
Comment

INTERMEDIATE RESULTS INDICATORS

INDICATOR		BASELINE	CURRENT	TARGET

Number of clinical trial sites that are GCP compliant Value 0.00 0.00 1.00
Date November 14, 2016 April 16, 2020
Comment
Number of product development agreements in place Value 0.00 61.00 9.00
Date November 14, 2016 April 16, 2020
Comment
Number of registered technology transfer professionals qualified Value 0.00 11.00 0.00
Date November 14, 2016 April 16, 2020
Comment
Number of international publications Value 0.00 2.00 1.00
Date November 14, 2016 April 16, 2020
Comment
Number of people trained Value 0.00 1183.00 165.00
Date November 14, 2017 April 16, 2020
Comment
Proportion of grievances responded to and/or resolved within the stipulated service standards for response times Value 0.00 100.00 90.00
Date November 14, 2016 April 16, 2020
Comment
Number of people trained who are women Value 0.00 31.00 50.00
Date November 14, 2017
Comment

Number of products addressing public health priorities advanced at least one step on the product development pathway	Value	0.00	7.00	0.00
	Date	November 14, 2016	April 16, 2020
	Comment

Number of TTOs established	Value	0.00	5.00	0.00
	Date	November 14, 2017	April 16, 2020
	Comment

Number of international publications	Value	0.00	2.00	1.00
	Date	November 14, 2016	April 16, 2020
	Comment

Number of people trained	Value	0.00	1183.00	165.00
	Date	November 14, 2017	April 16, 2020
	Comment

Number of people trained who are women	Value	0.00	31.00	50.00
	Date	November 14, 2017
	Comment

Proportion of grievances responded to and/or resolved within the stipulated service standards for response times	Value	0.00	100.00	90.00
	Date	November 14, 2016	April 16, 2020
	Comment

Innovate in India for Inclusiveness

Abstract*

Development Objective

Key Details

Project Details

Sectors

Themes

Stay Connected, sign up for our:

Project Map

Finances

Financing Plan (US$ Millions)

Total Project Financing (US$ Millions)

Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025

Detailed Financial Activity as of March 31, 2025

Ratings

IMPLEMENTATION RATINGS

COMPLETION RATINGS

INDEPENDENT EVALUATION RATINGS

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INTERMEDIATE RESULTS INDICATORS